https://investor.paxmangroup.com/mfn_news/ 2026-06-12T09:39:43+00:00 https://investor.paxmangroup.com/mfn_news/paxman-levererar-skalpkylningssystem-till-20-av-texas-oncologys-kliniker/ 2017-06-15T06:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-skalpkylningssystem-har-erhallit-fda-godkannande-i-taiwan/ 2017-06-29T05:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-skalpkylningssystem-har-godkants-av-anmat-i-argentina/ 2017-07-31T05:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-mer-an-halvvags-mot-volymmalet-for-forsta-aret-pa-usa-marknaden/ 2017-08-25T06:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-delarsrapport-per-30-juni-2017/ 2017-08-30T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-tidigarelagger-publiceringen-av-sin-q3-rapport/ 2017-09-20T18:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-ansoker-om-fda-godkannande-i-usa-for-vasentligt-utokad-anvandning-av-bolagets-skalpkylningssystem/ 2017-10-06T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-installerar-skalpkylningssystem-hos-memorial-sloan-kettering-cancer-centre-msk/ 2017-11-01T18:15:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-ab-byter-certified-adviser-fran-erik-penser-bank-ab-till-fnca-sweden-ab/ 2017-11-10T12:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-justerar-bokfort-varde-av-anlaggningstillgangar-1-april-30-juni/ 2017-11-10T15:15:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-september-2017/ 2017-11-24T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-as-of-30-september-2017/ 2017-11-24T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-rorelsekredit-om-10-msek-till-finansiell-buffert-for-att-kunna-oka-expansionstakten-i-usa/ 2018-01-22T15:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-a-10-msek-line-of-credit-as-a-financial-buffer-to-enable-increased-expansion-rate-in-the-us/ 2018-01-22T15:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-och-teva-pharmaceutical-industries-ltd-tecknar-licensavtal-for-paxman-scalp-cooler-i-mexiko/ 2018-01-31T13:55:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-and-teva-pharmaceutical-industries-ltd-announce-licensing-agreement-for-paxman-scalp-cooler-in-the-mexico-market/ 2018-01-31T13:55:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-tecknar-avtal-med-md-anderson-cancer-center/ 2018-02-19T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-forstarker-ir-kommunikationen-med-honeybadger/ 2018-02-20T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-summarized-financial-statements-as-of-31-december-2017/ 2018-02-27T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-bokslutskommunike-per-31-december-2017/ 2018-02-27T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-levererar-skalpkylning-till-samtliga-fem-topprankade-cancercenter-i-usa/ 2018-02-27T13:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-scalp-cooling-system-available-at-all-the-five-highest-ranked-cancer-centres-in-the-usa/ 2018-02-27T13:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-nar-milstolpe-om-250-skalpkylningssystem-i-usa-inklusive-nytt-avtal-med-topp-tio-rankat-cancercenter/ 2018-03-05T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-reaches-milestone-of-250-scalp-cooling-systems-in-the-usa-including-a-new-agreement-with-a-top-ten-ranked-cancer-center/ 2018-03-05T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-med-intervjuer-om-bolagets-framtidsutsikter-i-usa-samt-samarbetet-med-teva-i-mexiko/ 2018-03-20T15:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-lamnar-in-ansokan-om-marknadsgodkannande-i-japan/ 2018-04-05T11:15:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-submits-application-for-market-approval-in-japan/ 2018-04-05T11:15:00+00:00 https://investor.paxmangroup.com/mfn_news/notice-of-the-annual-general-meeting-for-paxman-ab-3/ 2018-04-16T05:30:00+00:00 https://investor.paxmangroup.com/mfn_news/kallelse-till-arsstamma-i-paxman-ab-publ-9/ 2018-04-16T05:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-market-approval-in-mexico-and-plans-q2-launch-with-license-partner-teva-pharmaceutical-industries-ltd/ 2018-04-19T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-marknadsgodkannande-i-mexiko-och-planerar-lansering-under-q2-med-licenspartnern-teva-pharmaceutical-industries-ltd/ 2018-04-19T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-amends-acquisition-value-of-paxman-group-ltd-and-year-end-figures/ 2018-04-27T11:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-rekonstruerar-forvarvsanalysen-for-paxman-group-ltd-och-justerar-helarssiffror-for-2017/ 2018-04-27T11:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-annual-report-for-2017/ 2018-04-27T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-arsredovisning-for-2017/ 2018-04-27T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-kompletterar-ansokan-om-utokat-fda-godkannande-i-usa/ 2018-05-08T08:35:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-supplements-application-for-expanded-fda-clearance-in-the-usa/ 2018-05-08T08:35:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-31-mars-2018/ 2018-05-24T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-the-period-1-january-to-31-march-2018/ 2018-05-24T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/kommunike-fran-arsstamma-i-paxman-ab-publ-9/ 2018-05-24T14:45:00+00:00 https://investor.paxmangroup.com/mfn_news/press-release-from-paxman-abs-2018-annual-general-meeting/ 2018-05-24T14:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-utokat-fda-godkannande-i-usa-for-bolagets-skalpkylningssystem/ 2018-06-07T15:15:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-fda-clearance-for-an-expanded-indication-of-its-scalp-cooling-system-in-the-us/ 2018-06-07T15:15:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-bolagets-utokade-usa-godkannande-samt-starka-kliniska-studieresultat/ 2018-06-12T14:10:16+00:00 https://investor.paxmangroup.com/mfn_news/paxman-comments-on-ama-decision-on-cpt-code-for-scalp-cooling/ 2018-06-19T16:25:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-kommenterar-ama-beslut-om-cpt-kod-for-skalpkylning/ 2018-06-19T16:25:00+00:00 https://investor.paxmangroup.com/mfn_news/information-om-insiderforsaljningar-i-paxman-ab-publ-2/ 2018-07-03T05:24:45+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-first-order-from-teva-in-mexico-for-17-scalp-cooling-systems/ 2018-07-17T13:35:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-forsta-ordern-fran-teva-i-mexiko-om-17-skalpkylningssystem/ 2018-07-17T13:35:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-the-period-1-april-to-30-june-2018/ 2018-08-30T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-delarsrapport-per-30-juni-2018/ 2018-08-30T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-bolagets-starka-utveckling-i-usa-mexiko-och-globalt/ 2018-09-14T09:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-presenterar-bolaget-pa-stora-aktiedagen-den-26-november/ 2018-11-12T12:28:05+00:00 https://investor.paxmangroup.com/mfn_news/paxman-to-present-the-company-at-stora-aktiedagen-on-26-november/ 2018-11-12T12:30:42+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-september-2018/ 2018-11-22T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-the-period-1-july-to-30-september-2018/ 2018-11-22T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-andra-order-av-teva-i-mexiko-efter-framgangsrik-marknadslansering/ 2018-12-19T11:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-second-order-from-teva-in-mexico-following-successful-market-launch/ 2018-12-19T11:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-order-om-tva-skalpkylningssystem-till-sundsvalls-sjukhus/ 2019-01-28T13:13:40+00:00 https://investor.paxmangroup.com/mfn_news/paxman-to-develop-medical-cooling-device-to-prevent-nerve-damage-in-chemotherapy-patients-with-national-university-hospital-singapore/ 2019-01-30T15:19:50+00:00 https://investor.paxmangroup.com/mfn_news/paxman-inleder-utveckling-av-kylningsprodukt-som-motverkar-nervskador-hos-cellgiftspatienter-med-nationellt-universitetssjukhus-i-singapore/ 2019-01-30T15:19:51+00:00 https://investor.paxmangroup.com/mfn_news/paxman-ab-publ-paxman-publicerar-nyhetsbrev-om-bolagets-nya-indikation-cipn-samt-den-dubbla-vinsten-vid-eef-future-manufacturing-awards/ 2019-02-13T14:31:24+00:00 https://investor.paxmangroup.com/mfn_news/paxman-ab-publ-paxman-publishes-newsletter-on-its-new-cipn-indication-and-the-double-win-at-the-eef-future-manufacturing-awards/ 2019-02-13T14:31:24+00:00 https://investor.paxmangroup.com/mfn_news/paxman-ab-publ-paxman-and-university-of-huddersfield-invest-12-msek-over-5-years-into-worlds-first-scalp-cooling-research-and-development-centre/ 2019-02-25T14:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-ab-publ-paxman-och-huddersfields-universitet-investerar-12-msek-under-5-ar-i-varldens-forsta-forsknings-och-utvecklingscenter-inom-skalpkylning/ 2019-02-25T14:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-ab-publ-paxman-publishes-its-year-end-report-january-december-2018/ 2019-02-27T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-ab-publ-paxman-publicerar-bokslutskommunike-januari-december-2018/ 2019-02-27T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-ab-publ-paxman-meddelar-att-nccns-riktlinjer-nu-rekommenderar-skalpkylning-som-en-kategori-2a-behandling-for-patienter-med-brostcancer/ 2019-03-17T15:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-ab-publ-the-nccn-guidelines-now-recommend-scalp-cooling-as-a-category-2a-treatment-option-for-patients-with-invasive-breast-cancer/ 2019-03-17T15:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-market-approval-in-japan-will-initiate-comprehensive-marketing-activities-in-2019/ 2019-03-28T10:15:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-marknadsgodkannande-i-japan-kommer-att-inleda-omfattande-marknadsaktiviteter-under-2019/ 2019-03-28T10:15:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-order-om-20-skalpkylningssystem-till-japan-tva-veckor-efter-marknadsgodkannande/ 2019-04-11T12:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-order-for-20-scalp-cooling-systems-to-japan-two-weeks-after-market-approval/ 2019-04-11T12:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-companys-market-approval-in-japan/ 2019-04-15T13:15:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-bolagets-marknadsgodkannande-i-japan/ 2019-04-15T13:15:00+00:00 https://investor.paxmangroup.com/mfn_news/notice-of-the-annual-general-meeting-for-paxman-ab-2/ 2019-04-17T09:35:00+00:00 https://investor.paxmangroup.com/mfn_news/kallelse-till-arsstamma-i-paxman-ab-publ-8/ 2019-04-17T09:35:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-that-the-state-of-texas-is-preparing-a-bill-proposing-mandatory-coverage-of-scalp-cooling-costs/ 2019-04-17T14:47:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-meddelar-att-delstaten-texas-i-usa-utreder-ett-lagforslag-om-obligatorisk-kostnadstackning-for-skalpkylning/ 2019-04-17T14:47:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-annual-report-for-2018/ 2019-05-07T12:20:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-arsredovisning-for-2018/ 2019-05-07T12:20:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-reaches-milestone-of-500-scalp-cooling-systems-in-the-usa/ 2019-05-13T08:58:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-nar-milstolpe-om-500-skalpkylningssystem-i-usa/ 2019-05-13T08:58:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-meddelar-att-lagforslag-om-kostnadstackning-for-skalpkylning-inte-gick-igenom-i-texas/ 2019-05-21T12:08:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-that-bill-for-mandatory-coverage-of-scalp-cooling-costs-was-rejected-in-texas/ 2019-05-21T12:08:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q1-2019/ 2019-05-23T10:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-31-mars-2019/ 2019-05-23T10:30:00+00:00 https://investor.paxmangroup.com/mfn_news/press-release-from-paxman-abs-2019-annual-general-meeting/ 2019-05-23T14:40:00+00:00 https://investor.paxmangroup.com/mfn_news/kommunike-fran-arsstamma-i-paxman-ab-publ-8/ 2019-05-23T14:40:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-market-registration-in-brazil-for-its-latest-scalp-cooling-system/ 2019-06-18T10:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-marknadsregistrering-i-brasilien-for-bolagets-senaste-skalpkylningssystem/ 2019-06-18T10:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-bolagets-expansion-i-sydamerika-samt-nyligen-erhallet-designpris/ 2019-06-19T14:48:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-companys-expansion-in-south-america-and-a-recently-received-design-award/ 2019-06-19T14:48:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-order-for-10-scalp-cooling-systems-to-australia/ 2019-06-20T08:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-order-om-10-skalpkylningssystem-till-australien/ 2019-06-20T08:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-marknadsgodkannande-i-sydafrika-for-pscs-bolagets-senaste-skalpkylningssystem/ 2019-08-20T08:33:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-market-registration-in-south-africa-for-its-latest-pscs-scalp-cooling-system/ 2019-08-20T08:33:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-forstarker-sin-marknadsnarvaro-i-asien-med-distributionsavtal-for-pakistan/ 2019-08-21T07:55:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-strengthens-its-market-presence-in-asia-with-distribution-agreement-for-pakistan/ 2019-08-21T07:55:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-delarsrapport-per-30-juni-2019/ 2019-08-29T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q2-2019/ 2019-08-29T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-companys-expansion-in-africa-and-asia-and-three-poster-presentations-at-esmo-in-barcelona/ 2019-09-13T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-bolagets-expansion-i-afrika-och-asien-samt-presentation-av-tre-kliniska-studier-vid-esmo-i-barcelona/ 2019-09-13T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-order-for-20-additional-scalp-cooling-systems-to-japan/ 2019-09-13T14:08:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-order-om-ytterligare-20-skalpkylningssystem-till-japan/ 2019-09-13T14:08:00+00:00 https://investor.paxmangroup.com/mfn_news/information-om-insiderforsaljningar-i-paxman-ab-publ/ 2019-10-01T16:30:00+00:00 https://investor.paxmangroup.com/mfn_news/information-on-insider-transactions-in-paxman-ab-publ/ 2019-10-01T16:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-bolagets-expansion-i-japan-och-aktiviteter-under-oktober-breast-cancer-awareness-month/ 2019-10-17T13:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-companys-expansion-in-japan-and-events-during-october-breast-cancer-awareness-month/ 2019-10-17T13:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q3-2019/ 2019-11-21T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-september-2019/ 2019-11-21T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-bolagets-rekordstarka-q3-resultat-samt-distributionsavtal-i-israel-och-rumanien/ 2019-11-29T11:28:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-companys-record-q3-result-and-distribution-agreements-in-israel-and-romania/ 2019-11-29T11:28:00+00:00 https://investor.paxmangroup.com/mfn_news/nordic-asset-manager-bankinvest-buys-200000-shares-in-paxman-ab-publ/ 2019-12-03T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/nordiska-kapitalforvaltaren-bankinvest-koper-200-000-aktier-i-paxman-ab-publ/ 2019-12-03T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-marknadsgodkannande-i-argentina-for-bolagets-senaste-skalpkylningssystem/ 2019-12-12T08:58:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-market-clearance-in-argentina-for-its-latest-scalp-cooling-system/ 2019-12-12T08:58:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-ab-publ-appoints-new-chief-financial-officer/ 2020-01-14T14:40:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-ab-publ-utser-ny-chief-financial-officer/ 2020-01-14T14:40:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-uppgraderingar-till-bolagets-senaste-system-i-storbritannien/ 2020-01-27T09:18:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-upgrades-to-the-companys-latest-system-in-the-uk/ 2020-01-27T09:18:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-order-om-16-skalpkylningssystem-till-storbritannien-samt-10-system-till-italien/ 2020-02-17T09:13:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-orders-for-16-scalp-cooling-systems-to-the-uk-and-10-systems-to-italy/ 2020-02-17T09:13:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-year-end-report-for-2019/ 2020-02-21T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-bokslutskommunike-per-31-december-2019/ 2020-02-21T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-with-ceo-richard-paxman-answering-shareholders-questions-on-the-companys-year-end-report/ 2020-02-26T16:11:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-dar-vd-richard-paxman-svarar-pa-aktieagarfragor-om-bolagets-bokslutskommunike/ 2020-02-26T16:11:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-coronavirus-situation-and-recent-order-shipments-of-11-systems-to-australia-and-10-systems-to-japan/ 2020-03-20T10:25:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-coronavirus-situationen-samt-leveranser-om-11-system-till-australien-och-10-system-till-japan/ 2020-03-20T10:25:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-nccns-inkludering-av-skalpkylning-i-sina-riktlinjer-for-aggstockscancer-samt-uppdaterar-om-coronavirus-atgarder/ 2020-04-02T09:36:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-nccns-inclusion-of-scalp-cooling-in-its-guidelines-for-ovarian-cancer-and-updates-on-pre-emptive-coronavirus-measures/ 2020-04-02T09:36:00+00:00 https://investor.paxmangroup.com/mfn_news/kallelse-till-arsstamma-i-paxman-ab-publ-7/ 2020-04-24T09:00:00+00:00 https://investor.paxmangroup.com/mfn_news/notice-of-the-annual-general-meeting-for-paxman-ab/ 2020-04-24T09:00:00+00:00 https://investor.paxmangroup.com/mfn_news/rattelse-kallelse-till-arsstamma-i-paxman-ab-publ/ 2020-04-24T09:07:00+00:00 https://investor.paxmangroup.com/mfn_news/correction-notice-of-the-annual-general-meeting-for-paxman-ab/ 2020-04-24T09:07:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-order-och-kommande-leveranser-samt-bolagets-digitala-support-till-patienter-och-kunder-under-covid-19/ 2020-04-29T07:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-orders-and-upcoming-deliveries-how-it-is-supporting-its-patients-and-customers-digitally-through-covid-19/ 2020-04-29T07:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-bolagets-arsredovisning-for-2019/ 2020-05-06T09:34:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-the-companys-annual-report-for-2019/ 2020-05-06T09:34:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q1-2020/ 2020-05-27T10:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-for-kvartal-1-2020/ 2020-05-27T10:30:00+00:00 https://investor.paxmangroup.com/mfn_news/press-release-from-paxman-abs-2020-annual-general-meeting/ 2020-05-27T14:40:00+00:00 https://investor.paxmangroup.com/mfn_news/kommunike-fran-arsstamma-i-paxman-ab-publ-7/ 2020-05-27T14:40:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-positiva-kliniska-resultat-i-japansk-forskningsstudie/ 2020-06-30T07:02:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-positive-data-from-recently-published-clinical-study-in-japan/ 2020-06-30T07:02:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-strong-development-in-france-despite-the-covid-19-pandemic/ 2020-08-14T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-stark-utveckling-i-frankrike-trots-covid-19-pandemin/ 2020-08-14T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-juni-2020/ 2020-08-27T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q2-2020/ 2020-08-27T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-significant-sales-in-the-uk-and-continued-progress-in-the-development-of-a-cipn-product/ 2020-09-15T13:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-signifikant-forsaljning-i-storbritannien-och-fortsatta-framsteg-inom-utvecklingen-av-en-cipn-produkt/ 2020-09-15T13:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-meddelar-att-cancer-australias-riktlinjer-for-hantering-av-tidig-brostcancer-nu-rekommenderar-skalpkylning/ 2020-09-22T06:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-that-cancer-australias-guidance-for-the-management-of-early-breast-cancer-now-recommends-scalp-cooling/ 2020-09-22T06:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-godkannandet-av-en-kommande-studie-med-bolagets-skalpkylningssystem-i-sydkorea/ 2020-10-20T12:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-approval-of-an-upcoming-study-with-the-companys-scalp-cooling-system-in-south-korea/ 2020-10-20T12:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-meddelar-att-cpt-editorial-panel-upprattar-ctp-kod-for-skalpkylning/ 2020-10-30T19:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-that-cpt-editorial-panel-establishes-cpt-code-for-mechanical-scalp-cooling/ 2020-10-30T19:10:00+00:00 https://investor.paxmangroup.com/mfn_news/reminder-dont-miss-to-register-to-the-virtual-qa-with-richard-paxman-on-november-25/ 2020-11-05T14:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paminnelse-glom-inte-att-anmala-dig-till-det-virtuella-qa-eventet-med-vd-richard-paxman-den-25-november/ 2020-11-05T14:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q3-2020/ 2020-11-20T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-september-2020/ 2020-11-20T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-cpt-code-for-scalp-cooling-in-the-us-and-several-new-installations-in-the-us-and-the-uk/ 2020-11-26T08:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-cpt-kod-for-skalpkylning-i-usa-och-flertalet-nya-installationer-i-usa-och-storbritannien/ 2020-11-26T08:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-order-om-10-system-till-italien/ 2020-12-10T13:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-order-for-10-scalp-cooling-systems-for-the-italian-market/ 2020-12-10T13:10:00+00:00 https://investor.paxmangroup.com/mfn_news/european-society-for-medical-oncology-esmo-clinical-practice-guidelines-recommends-scalp-cooling-to-prevent-chemotherapy-induced-alopecia/ 2020-12-16T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/european-society-for-medical-oncology-esmo-rekommenderar-skalpkylning-i-samband-med-cellgiftsbehandling-for-att-minska-risken-for-haravfall/ 2020-12-16T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-that-scalp-cooling-is-now-recommended-in-esmos-european-clinical-practical-guidelines-for-cancer-treatments/ 2020-12-18T07:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-att-skalpkylning-nu-rekommenderas-i-esmos-europeiska-kliniska-riktlinjer-for-cancerbehandling/ 2020-12-18T07:30:00+00:00 https://investor.paxmangroup.com/mfn_news/ama-issues-cpt-category-iii-codes-for-mechanical-scalp-cooling/ 2021-01-03T14:50:00+00:00 https://investor.paxmangroup.com/mfn_news/ama-utfardar-cpt-kategori-iii-koder-for-mekanisk-skalpkylning/ 2021-01-03T14:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-comments-on-the-national-lockdown-in-the-uk/ 2021-01-05T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-kommenterar-den-landsomfattande-nedstangningen-i-storbritannien/ 2021-01-05T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-that-american-medical-association-ama-issues-cpt-category-iii-codes-for-mechanical-scalp-cooling/ 2021-01-22T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-att-american-medical-association-ama-infor-cpt-kategori-iii-koder-for-mekanisk-skalpkylning/ 2021-01-22T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-carries-out-a-directed-issue-of-1600000-shares-and-hereby-receives-approximately-sek-59-million/ 2021-02-02T18:14:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-genomfor-riktad-nyemission-om-1-600-000-aktier-och-tillfors-harigenom-cirka-59-miljoner-kronor/ 2021-02-02T18:14:00+00:00 https://investor.paxmangroup.com/mfn_news/rattelse-paxman-genomfor-riktad-nyemission-om-1-600-000-aktier-och-tillfors-harigenom-cirka-59-miljoner-kronor/ 2021-02-02T18:42:00+00:00 https://investor.paxmangroup.com/mfn_news/correction-paxman-carries-out-a-directed-issue-of-1600000-shares-and-hereby-receives-approximately-sek-59-million/ 2021-02-02T18:42:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-varldens-forsta-biologiska-forskningsresultat-som-visar-hur-skalpkylning-skyddar-manskliga-harsackar/ 2021-02-24T15:35:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-worlds-first-biological-evidence-of-how-scalp-cooling-works-to-protect-human-hair-follicles/ 2021-02-24T15:35:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-bokslutskommunike-per-31-december-2020/ 2021-02-26T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-year-end-report-for-2020/ 2021-02-26T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/first-non-cancer-scalp-cooling-study-for-the-prevention-of-chemotherapy-induced-hair-loss-in-pediatric-patients/ 2021-02-26T14:40:00+00:00 https://investor.paxmangroup.com/mfn_news/forsta-skalpkylningsstudien-med-icke-cancerpatienter-for-att-motverka-cellgiftsinducerat-haravfall-hos-barn-och-unga/ 2021-02-26T14:40:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-in-which-ceo-richard-paxman-answers-shareholders-questions-following-the-year-end-report/ 2021-03-30T07:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-i-vilket-vd-richard-paxman-svarar-pa-aktieagarnas-fragor-efter-bokslutskommuniken/ 2021-03-30T07:45:00+00:00 https://investor.paxmangroup.com/mfn_news/bill-for-mandatory-coverage-of-scalp-cooling-passed-by-texas-house-committee/ 2021-04-20T07:15:00+00:00 https://investor.paxmangroup.com/mfn_news/proposition-for-obligatorisk-tackning-av-skalpkylning-godkand-av-texas-house-kommitten/ 2021-04-20T07:15:00+00:00 https://investor.paxmangroup.com/mfn_news/the-shareholders-of-paxman-ab-publ-the-company-are-hereby-invited-to-attend-the-annual-general-meeting-on-wednesday-26-may-2021-at-1500-cet/ 2021-04-26T07:58:00+00:00 https://investor.paxmangroup.com/mfn_news/kallelse-till-arsstamma-i-paxman-ab-publ-6/ 2021-04-26T07:58:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-japanese-study-showing-that-paxmans-scalp-cooling-has-preventive-effects-against-permanent-hair-loss/ 2021-04-27T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-japansk-studie-som-visar-att-paxmans-skalpkylning-motverkar-permanent-haravfall/ 2021-04-27T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-global-distribution-network-grows-with-addition-of-two-new-partners-for-chile-and-ukraine/ 2021-05-06T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-utokar-sitt-globala-natverk-med-ytterligare-tva-nya-partners-for-chile-och-ukraina/ 2021-05-06T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-the-companys-annual-report-for-2020/ 2021-05-07T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-bolagets-arsredovisning-for-2020/ 2021-05-07T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/view-ceo-richard-paxmans-participation-in-redeyes-virtual-medtech-diagnostics-event-may-5th/ 2021-05-11T08:30:00+00:00 https://investor.paxmangroup.com/mfn_news/se-vd-richard-paxmans-deltagande-vid-redeyes-virituella-medtech-diagnostics-event-5-maj/ 2021-05-11T08:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-singapore-uk-team-to-develop-a-novel-device-to-reduce-chemotherapy-side-effects/ 2021-05-21T13:35:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-tillkannager-singapore-uk-teamet-som-utvecklar-en-unik-enhet-for-att-minska-biverkningar-av-kemoterapi/ 2021-05-21T13:35:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q1-2021/ 2021-05-26T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-31-mars-2021/ 2021-05-26T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/press-release-from-paxman-abs-2021-annual-general-meeting/ 2021-05-26T14:02:00+00:00 https://investor.paxmangroup.com/mfn_news/kommunike-fran-arsstamma-i-paxman-ab-publ-6/ 2021-05-26T14:02:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-research-grant-to-the-companys-development-of-a-product-to-prevent-chemotherapy-induced-peripheral-neuropathy-cipn/ 2021-05-28T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-forskningsanslag-till-bolagets-utveckling-av-en-produkt-som-motverkar-cellgiftsinducerad-perifer-neuropati-cipn/ 2021-05-28T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/redeye-publishes-analysis-of-paxman/ 2021-06-16T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/redeye-publicerar-analys-av-paxman/ 2021-06-16T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-signs-new-distribution-agreements-with-partners-in-indonesia-and-bangladesh/ 2021-06-18T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-tecknar-nya-distributionsavtal-med-partners-i-indonesien-och-bangladesh/ 2021-06-18T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-new-distribution-partners-in-indonesia-and-bangladesh/ 2021-06-29T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-nya-distributionspartners-i-indonesien-samt-bangladesh/ 2021-06-29T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q2-2021/ 2021-08-27T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-juni-2021/ 2021-08-27T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/see-redeyes-interview-with-ceo-richard-paxman-11/ 2021-08-30T08:40:00+00:00 https://investor.paxmangroup.com/mfn_news/se-redeyes-intervju-med-vd-richard-paxman-11/ 2021-08-30T08:40:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-strong-international-order-and-installation-activity-during-the-summer/ 2021-08-30T09:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-stark-internationell-order-och-installationsaktivitet-under-sommaren/ 2021-08-30T09:00:00+00:00 https://investor.paxmangroup.com/mfn_news/ceo-richard-paxman-participates-in-investor-forum-online/ 2021-09-22T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/vd-richard-paxman-deltar-vid-investor-forum-online/ 2021-09-22T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-companys-relaunch-in-the-canadian-market/ 2021-09-24T06:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-bolagets-aterkomst-till-den-kanadensiska-marknaden/ 2021-09-24T06:30:00+00:00 https://investor.paxmangroup.com/mfn_news/see-ceo-richard-paxmans-participation-in-redeyes-investor-forum/ 2021-09-27T10:30:00+00:00 https://investor.paxmangroup.com/mfn_news/se-vd-richard-paxmans-deltagande-vid-redeyes-investor-forum/ 2021-09-27T10:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-media-attention-and-marketing-during-breast-cancer-awareness-month/ 2021-10-27T09:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-medieuppmarksamhet-och-marknadsforing-under-internationella-brostcancermanaden/ 2021-10-27T09:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-that-us-centers-for-medicare-and-medicaid-services-cms-has-reassigned-payment-for-scalp-cooling/ 2021-11-03T11:35:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-meddelar-att-us-centers-for-medicare-and-medicaid-services-cms-har-omtilldelat-betalningen-for-skalpkylning/ 2021-11-03T11:35:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-opens-cipn-clinical-trial-with-national-university-hospital-singapore/ 2021-11-04T14:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-inleder-klinisk-provning-for-cipn-med-national-university-hospital-singapore/ 2021-11-04T14:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announce-nelson-arcos-s-a-as-their-global-distribution-partner-for-paxman-equipment-in-uruguay/ 2021-11-11T08:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-tillkannager-nelson-arcos-s-a-som-sin-globala-distributionspartner-for-paxman-utrustning-i-uruguay/ 2021-11-11T08:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q3-2021/ 2021-11-19T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-september-2021/ 2021-11-19T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/redeyes-interview-and-updated-analysis-in-connection-with-the-q3-report/ 2021-11-23T10:35:00+00:00 https://investor.paxmangroup.com/mfn_news/redeyes-intervju-samt-uppdaterade-analys-i-samband-med-publicering-av-q3-rapporten/ 2021-11-23T10:35:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-a-significant-step-forward-for-scalp-cooling-access-in-the-united-states/ 2021-11-24T09:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-viktigt-framsteg-for-tillgangen-till-skalpkylning-i-usa/ 2021-11-24T09:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-avser-att-genomfora-en-riktad-nyemission-av-aktier/ 2021-12-16T16:31:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-intends-to-carry-out-a-directed-issue-of-shares/ 2021-12-16T16:31:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-has-carried-out-a-directed-share-issue-of-1400000-shares-at-a-subscription-price-of-sek-55-per-share/ 2021-12-16T19:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-har-genomfort-en-riktad-nyemission-av-1-400-000-aktier-till-en-teckningskurs-om-55-kronor-per-aktie/ 2021-12-16T19:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-companys-recent-77-msek-directed-share-issue/ 2021-12-21T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-bolagets-nyligen-genomforda-riktade-nyemission-om-77-msek/ 2021-12-21T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-internationalisation-of-the-companys-patient-support-website/ 2022-01-28T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-internationalisering-av-bolagets-patientfokuserade-webbplats/ 2022-01-28T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-launch-of-its-scalp-cooling-clinical-research-data-website/ 2022-02-25T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-sin-lansering-av-en-webbplats-med-skalpkylningsstudier-och-forskningsdata/ 2022-02-25T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-year-end-report-for-2021/ 2022-02-25T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-bokslutskommunike-per-31-december-2021/ 2022-02-25T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/see-redeyes-interview-with-ceo-richard-paxman-10/ 2022-02-28T10:40:00+00:00 https://investor.paxmangroup.com/mfn_news/se-redeyes-intervju-med-vd-richard-paxman-10/ 2022-02-28T10:40:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-the-worlds-first-scalp-cooling-summit-in-may/ 2022-03-28T14:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-varldens-forsta-scalp-cooling-summit-som-genomfors-i-maj/ 2022-03-28T14:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-signs-new-distribution-agreement-with-partner-in-serbia/ 2022-03-30T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-skriver-nytt-distributionsavtal-med-partner-i-serbien/ 2022-03-30T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/bill-introduced-to-increase-access-to-scalp-cooling-therapy/ 2022-04-05T08:35:00+00:00 https://investor.paxmangroup.com/mfn_news/lagforslag-presenterat-med-syfte-att-oka-tillgangen-till-skalpkylningsterapi/ 2022-04-05T08:35:00+00:00 https://investor.paxmangroup.com/mfn_news/information-on-pdmr-transaction-in-paxman-ab-publ/ 2022-04-05T16:17:00+00:00 https://investor.paxmangroup.com/mfn_news/information-om-insynspersonsforsaljning-i-paxman-ab-publ/ 2022-04-05T16:17:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-signs-a-letter-of-interest-with-a-chinese-partner-to-enter-into-a-distribution-and-marketing-agreement-to-jointly-develop-the-chinese-market-for-the-paxman-scalp-cooler/ 2022-04-12T08:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-undertecknar-ett-letter-of-interest-med-en-kinesisk-partner-med-syfte-att-inga-ett-distributions-och-marknadsforingsavtal-for-att-gemensamt-utveckla-den-kinesiska-marknaden-for-paxman-scalp-co/ 2022-04-12T08:50:00+00:00 https://investor.paxmangroup.com/mfn_news/the-shareholders-of-paxman-ab-publ-the-company-are-hereby-invited-to-attend-the-annual-general-meeting-on-wednesday-25-may-2022-at-1500-cet/ 2022-04-25T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/kallelse-till-arsstamma-i-paxman-ab-publ-5/ 2022-04-25T12:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-a-new-bill-in-the-usa-to-increase-access-to-scalp-cooling/ 2022-04-29T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-ett-nytt-lagforslag-i-usa-for-att-oka-tillgangen-till-skalpkylning/ 2022-04-29T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-the-companys-annual-report-for-2021/ 2022-05-06T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-bolagets-arsredovisning-for-2021/ 2022-05-06T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-lanserar-en-forbattrad-assitanstjanst-for-leverantorer-och-patienter-samt-erbjuder-en-ny-affarsmodell/ 2022-05-09T12:40:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-launches-enhanced-provider-and-patient-assistance-services-as-well-as-offering-a-new-business-model-to-health-systems/ 2022-05-09T12:40:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-31-mars-2022/ 2022-05-25T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q1-2022/ 2022-05-25T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-successful-scalp-cooling-summit-with-around-50-speakers-and-1400-delegates/ 2022-05-25T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-framgangsrikt-scalp-cooling-summit-med-omkring-50-talare-och-1-400-deltagare/ 2022-05-25T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/press-release-from-paxman-abs-2022-annual-general-meeting/ 2022-05-25T14:05:00+00:00 https://investor.paxmangroup.com/mfn_news/kommunike-fran-arsstamma-i-paxman-ab-publ-5/ 2022-05-25T14:05:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-ama-resolutions-to-advocate-for-universal-insurance-coverage-of-scalp-cooling/ 2022-06-22T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-ama-beslut-i-usa-att-framja-allman-forsakringstackning-av-skalpkylning/ 2022-06-22T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-that-a-sustained-medicare-payment-rate-for-scalp-cooling-is-proposed-for-2023/ 2022-08-23T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-att-bibehallen-medicare-ersattningsniva-for-skalpkylning-foreslas-for-2023/ 2022-08-23T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q2-2022/ 2022-08-24T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-juni-2022/ 2022-08-24T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/see-redeyes-interview-with-ceo-richard-paxman-9/ 2022-08-24T11:55:00+00:00 https://investor.paxmangroup.com/mfn_news/se-redeyes-intervju-med-vd-richard-paxman-9/ 2022-08-24T11:55:00+00:00 https://investor.paxmangroup.com/mfn_news/redeye-publishes-analysis-of-paxmans-report/ 2022-08-26T07:10:00+00:00 https://investor.paxmangroup.com/mfn_news/redeye-analyserar-paxmans-kvartalsrapport/ 2022-08-26T07:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-starkt-orderflode-fran-usa-storbritannien-och-internationellt/ 2022-09-26T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-strong-order-flow-from-the-usa-the-uk-and-international-markets/ 2022-09-26T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-clinical-study-with-black-and-latina-cancer-patients-with-textured-hair/ 2022-10-28T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-klinisk-studie-med-svarta-och-latinamerikanska-cancerpatienter-med-krulligt-eller-lockigt-har/ 2022-10-28T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-that-us-centers-for-medicare-and-medicaid-services-cms-has-maintained-the-payment-rate-for-scalp-cooling-for-2023/ 2022-11-02T17:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-meddelar-att-us-centers-for-medicare-medicaid-services-cms-har-bibehallit-ersattningsnivan-for-skalpkylning-for-2023/ 2022-11-02T17:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-limb-cryocompression-system-to-be-used-in-swog-cancer-research-network-study-testing-for-prevention-of-chemotherapy-induced-peripheral-neuropathy/ 2022-11-15T15:05:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-limb-cryocompression-system-i-swog-cancer-research-network-study-testing-for-att-motverka-cellgiftsinducerad-perifer-neuropati/ 2022-11-15T15:05:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q3-2022/ 2022-11-18T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-september-2022/ 2022-11-18T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/market-clearance-granted-for-paxman-scalp-cooling-in-south-korea/ 2022-11-21T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/marknadsgodkannande-beviljat-for-paxman-scalp-cooling-i-sydkorea/ 2022-11-21T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/see-redeyes-interview-with-ceo-richard-paxman-8/ 2022-11-22T09:30:00+00:00 https://investor.paxmangroup.com/mfn_news/se-redeyes-intervju-med-vd-richard-paxman-8/ 2022-11-22T09:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-maintained-payment-rate-from-cms-in-the-usa-in-2023/ 2022-11-28T14:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-bibehallen-niva-for-kostnadsersattning-fran-cms-i-usa-under-2023/ 2022-11-28T14:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-orders-to-several-markets-this-month/ 2022-12-22T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-order-till-flertalet-marknader-under-manaden/ 2022-12-22T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-engagement-of-u-s-based-investor-relations-services-provider-arrowhead-business-and-investment-decisions/ 2022-12-28T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-tillkannager-samarbete-med-usa-baserad-leverantor-av-tjanster-for-investerarrelationer-arrowhead-business-and-investment-decisions/ 2022-12-28T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/the-paxman-scalp-cooling-system-receives-eu-mdr-certification/ 2023-01-26T07:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-scalp-cooling-system-erhaller-eu-mdr-certifiering/ 2023-01-26T07:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-initiated-coverage-of-the-companys-share-in-the-united-states/ 2023-01-30T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-inledd-bevakning-av-bolagets-aktie-i-usa/ 2023-01-30T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-year-end-report-for-2022/ 2023-02-24T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-bokslutskommunike-per-31-december-2022/ 2023-02-24T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/see-redeyes-interview-with-ceo-richard-paxman-7/ 2023-02-24T12:30:00+00:00 https://investor.paxmangroup.com/mfn_news/se-redeyes-intervju-med-vd-richard-paxman-7/ 2023-02-24T12:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-sin-nyligen-erhallna-mdr-certifiering-enligt-eus-nya-regelverk/ 2023-02-27T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-its-recently-obtained-eu-mdr-certification/ 2023-02-27T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-newsletter-on-increasing-investor-interest-for-the-company-in-the-united-states/ 2023-03-31T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-nyhetsbrev-om-okande-investerarintresse-for-bolaget-i-usa/ 2023-03-31T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/the-shareholders-of-paxman-ab-publ-the-company-are-hereby-invited-to-attend-the-annual-general-meeting-on-wednesday-24-may-2023-at-1000-cest/ 2023-04-24T07:30:00+00:00 https://investor.paxmangroup.com/mfn_news/kallelse-till-arsstamma-i-paxman-ab-publ-4/ 2023-04-24T07:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-the-companys-annual-report-for-2022/ 2023-05-04T08:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-bolagets-arsredovisning-for-2022/ 2023-05-04T08:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q1-2023/ 2023-05-24T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-31-mars-2023/ 2023-05-24T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/press-release-from-paxman-abs-2023-annual-general-meeting/ 2023-05-24T09:20:00+00:00 https://investor.paxmangroup.com/mfn_news/kommunike-fran-arsstamma-i-paxman-ab-publ-4/ 2023-05-24T09:20:00+00:00 https://investor.paxmangroup.com/mfn_news/see-redeyes-interview-with-ceo-richard-paxman-6/ 2023-05-25T06:30:00+00:00 https://investor.paxmangroup.com/mfn_news/se-redeyes-intervju-med-vd-richard-paxman-6/ 2023-05-25T06:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-proposal-for-local-coverage-determination-of-scalp-cooling-therapy/ 2023-06-15T08:03:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-tillkannager-forslag-for-lokal-tackningsbestamning-av-skalpkylningsterapi/ 2023-06-15T08:03:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q2-2023/ 2023-08-24T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-juni-2023/ 2023-08-24T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/see-redeyes-interview-with-ceo-richard-paxman-5/ 2023-08-25T06:50:00+00:00 https://investor.paxmangroup.com/mfn_news/se-redeyes-intervju-med-vd-richard-paxman-5/ 2023-08-25T06:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-palmetto-gba-approves-first-local-coverage-determination-for-scalp-cooling-therapy/ 2023-10-03T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-tillkannager-att-palmetto-gba-godkanner-forsta-lokal-tackningsbestamning-for-skalpkylningsterapi/ 2023-10-03T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-that-us-centers-for-medicare-and-medicaid-services-cms-continues-to-support-scalp-cooling-but-decreases-rate-for-2024/ 2023-11-07T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-meddelar-att-us-centers-for-medicare-and-madicaid-services-cms-fortsatter-stodja-skalpkylning-men-minskar-ersattningsnivan-for-2024/ 2023-11-07T10:00:00+00:00 https://investor.paxmangroup.com/mfn_news/richard-paxman-obe-ceo-of-paxman-will-join-redeye-life-science-day-2023/ 2023-11-10T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/richard-paxman-obe-paxmans-vd-deltar-vid-redeye-life-science-day-2023/ 2023-11-10T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q3-2023/ 2023-11-17T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-september-2023/ 2023-11-17T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/see-redeyes-interview-with-ceo-richard-paxman-4/ 2023-11-17T16:00:00+00:00 https://investor.paxmangroup.com/mfn_news/se-redeyes-intervju-med-vd-richard-paxman-4/ 2023-11-17T16:00:00+00:00 https://investor.paxmangroup.com/mfn_news/see-ceo-richard-paxman-presents-at-redeye-life-science-day-2023-23-november/ 2023-11-27T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/se-vd-richard-paxmans-presentation-pa-redeye-life-science-day-2023-23-november/ 2023-11-27T11:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-ceo-richard-paxman-in-a-company-presentation-at-stora-aktiedagen-in-stockholm/ 2023-11-29T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-vd-richard-paxman-i-bolagspresentation-pa-stora-aktiedagen-i-stockholm/ 2023-11-29T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/record-year-for-paxman/ 2024-02-23T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/ett-rekordar-for-paxman/ 2024-02-23T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/se-redeyes-intervju-med-vd-richard-paxman-3/ 2024-02-23T09:53:00+00:00 https://investor.paxmangroup.com/mfn_news/see-redeyes-interview-with-ceo-richard-paxman-3/ 2024-02-23T09:53:00+00:00 https://investor.paxmangroup.com/mfn_news/the-shareholders-of-paxman-ab-publ-the-company-are-hereby-invited-to-attend-the-annual-general-meeting-on-thursday-23-may-2024-at-1200-cest/ 2024-04-19T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/kallelse-till-arsstamma-i-paxman-ab-publ-3/ 2024-04-19T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-the-companys-annual-report-for-2023/ 2024-04-26T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-bolagets-arsredovisning-for-2023/ 2024-04-26T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q1-2024/ 2024-05-23T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-31-mars-2024/ 2024-05-23T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/press-release-from-paxman-abs-2024-annual-general-meeting/ 2024-05-23T10:40:00+00:00 https://investor.paxmangroup.com/mfn_news/kommunike-fran-arsstamma-i-paxman-ab-publ-3/ 2024-05-23T10:40:00+00:00 https://investor.paxmangroup.com/mfn_news/mascc-afsos-isoo-2024-annual-meeting-features-presentation-of-important-preliminary-data-in-cryotherapy-side-effect-management-for-safety-efficacy-of-paxman-limb-cryocompression-device/ 2024-06-29T10:45:00+00:00 https://investor.paxmangroup.com/mfn_news/mascc-afsos-isoos-arsmote-2024-innefattar-presentation-av-viktiga-preliminara-data-inom-hantering-av-biverkningar-vid-kryoterapi-for-sakerhet-och-effekt-av-paxman-limb-cryocompression-device/ 2024-06-29T10:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-secures-contract-for-the-provision-of-scalp-cooling-systems-to-the-u-s-department-of-veterans-affairs-va-for-the-national-precision-oncology-program-npop/ 2024-07-03T14:40:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-sakrar-kontrakt-for-att-tillhandahalla-skalpkylningssystem-till-u-s-department-of-veterans-affairs-va-for-national-precision-oncology-program-npop/ 2024-07-03T14:40:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q2-2024/ 2024-08-21T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-juni-2024/ 2024-08-21T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-receives-an-initial-order-under-contract-for-the-provision-of-scalp-cooling-systems-to-the-u-s-department-of-veterans-affairs-va-for-the-national-precision-oncology-program-npop/ 2024-08-28T11:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-erhaller-den-forsta-ordern-enligt-avtalet-om-leverans-av-skalpkylningssystem-till-u-s-department-of-veterans-affairs-va-for-national-precision-oncology-program-npop/ 2024-08-28T11:50:00+00:00 https://investor.paxmangroup.com/mfn_news/analyst-group-interviews-ceo-richard-paxman/ 2024-09-27T12:10:00+00:00 https://investor.paxmangroup.com/mfn_news/analyst-group-intervjuar-vd-richard-paxman/ 2024-09-27T12:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-new-cpt-category-i-codes-from-the-american-medical-association-for-mechanical-scalp-cooling/ 2024-10-18T15:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-tillkannager-nya-cpt-kategori-i-koder-fran-american-medical-association-for-mekanisk-skalpkylning/ 2024-10-18T15:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-that-us-centers-for-medicare-and-medicaid-services-cms-continues-to-support-scalp-cooling-and-increases-rate-for-2025-beyond-the-initial-proposed-rate/ 2024-11-04T14:22:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-meddelar-att-amerikanska-centers-for-medicare-and-medicaid-services-cms-fortsatter-att-stodja-skalpkylning-och-hojer-taxan-for-2025/ 2024-11-04T14:22:00+00:00 https://investor.paxmangroup.com/mfn_news/strong-performance-continues/ 2024-11-15T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/fortsatt-stark-utveckling/ 2024-11-15T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/see-redeyes-interview-with-ceo-richard-paxman-2/ 2024-11-15T13:10:00+00:00 https://investor.paxmangroup.com/mfn_news/se-redeyes-intervju-med-vd-richard-paxman-2/ 2024-11-15T13:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-major-shareholders-are-reducing-their-shareholdings/ 2024-12-05T20:04:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-storagare-minskar-sina-aktieinnehav/ 2024-12-05T20:04:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-passage-of-new-york-law-requiring-insurance-coverage-of-scalp-cooling-devices-to-help-prevent-hair-loss-during-cancer-treatment/ 2024-12-16T14:15:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-meddelar-att-ett-lagforslag-i-new-york-har-antagits-som-kraver-forsakringsskydd-for-skalpkylningsapparater-for-att-forhindra-haravfall-under-cancerbehandling/ 2024-12-16T14:15:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-rekordsvit-fortsatter/ 2025-02-21T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-record-breaking-streak-continues/ 2025-02-21T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/see-redeyes-interview-with-ceo-richard-paxman/ 2025-02-21T11:48:00+00:00 https://investor.paxmangroup.com/mfn_news/se-redeyes-intervju-med-vd-richard-paxman/ 2025-02-21T11:48:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-is-making-a-recommended-takeover-offer-to-dignitana-shareholders/ 2025-03-18T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-lamnar-ett-rekommenderat-uppkopserbjudande-till-aktieagarna-i-dignitana/ 2025-03-18T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/correction-paxman-is-making-a-recommended-takeover-offer-to-dignitana-shareholders/ 2025-03-18T17:10:00+00:00 https://investor.paxmangroup.com/mfn_news/rattelse-paxman-lamnar-ett-rekommenderat-uppkopserbjudande-till-aktieagarna-i-dignitana/ 2025-03-18T17:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-intends-to-carry-out-a-directed-issue/ 2025-03-20T16:31:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-avser-att-genomfora-en-riktad-nyemission/ 2025-03-20T16:31:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-has-carried-out-a-directed-issue-of-1-9-million-new-shares-raising-proceeds-of-sek-123-5-million/ 2025-03-20T20:52:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-har-genomfort-en-riktad-nyemission-av-19-miljoner-aktier-om-1235-msek/ 2025-03-20T20:52:00+00:00 https://investor.paxmangroup.com/mfn_news/kallelse-till-extra-bolagsstamma-i-paxman-ab-publ/ 2025-03-24T09:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-offer-document-and-information-document-in-connection-with-the-recommended-takeover-bid-to-the-shareholders-of-dignitana/ 2025-04-07T16:15:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-offentliggor-erbjudandehandling-och-informationsdokument-med-anledning-av-det-rekommenderade-uppkopserbjudandet-till-aktieagarna-i-dignitana/ 2025-04-07T16:15:00+00:00 https://investor.paxmangroup.com/mfn_news/press-release-from-the-extra-general-meeting-of-paxman-ab-publ/ 2025-04-08T09:10:00+00:00 https://investor.paxmangroup.com/mfn_news/kommunike-fran-extra-bolagsstamma-i-paxman-ab-publ/ 2025-04-08T09:10:00+00:00 https://investor.paxmangroup.com/mfn_news/notice-of-agm-2025/ 2025-04-16T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/kallelse-till-arsstamma-i-paxman-ab-publ-2/ 2025-04-16T07:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-the-companys-annual-report-for-2024/ 2025-04-25T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-bolagets-arsredovisning-for-2024/ 2025-04-25T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/invitation-to-the-presentation-of-paxmans-q1-report-on-16-may/ 2025-04-29T12:10:00+00:00 https://investor.paxmangroup.com/mfn_news/inbjudan-till-presentationen-av-paxmans-delarsrapport-for-q1-den-16-maj/ 2025-04-29T12:10:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-completes-public-offer-to-dignitana-shareholders-and-extends-acceptance-period/ 2025-05-08T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-fullfoljer-uppkopserbjudandet-till-aktieagarna-i-dignitana-och-forlanger-acceptperioden/ 2025-05-08T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/strong-sales-support-continued-investment/ 2025-05-16T05:00:00+00:00 https://investor.paxmangroup.com/mfn_news/stark-forsaljning-mojliggor-fortsatt-investering/ 2025-05-16T05:00:00+00:00 https://investor.paxmangroup.com/mfn_news/press-release-from-paxman-abs-2025-annual-general-meeting/ 2025-05-16T09:05:00+00:00 https://investor.paxmangroup.com/mfn_news/kommunike-fran-arsstamma-i-paxman-ab-publ-2/ 2025-05-16T09:05:00+00:00 https://investor.paxmangroup.com/mfn_news/watch-ceo-richard-paxman-comment-on-the-q1-report/ 2025-05-19T07:30:00+00:00 https://investor.paxmangroup.com/mfn_news/se-vd-richard-paxman-kommentera-q1-rapporten/ 2025-05-19T07:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-outcome-following-extended-acceptance-period-of-the-takeover-bid-to-the-shareholders-of-dignitana/ 2025-06-02T05:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-offentliggor-utfallet-efter-den-forlangda-acceptperioden-i-uppkopserbjudandet-till-aktieagarna-i-dignitana/ 2025-06-02T05:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-initiates-commissioned-research-collaboration-with-carnegie/ 2025-06-30T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-inleder-samarbete-om-uppdragsanalys-med-carnegie/ 2025-06-30T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/medicare-physician-fee-schedule-proposed-rule-assigns-2026-payment-rates-to-three-new-cpt-codes-for-mechanical-scalp-cooling/ 2025-07-15T13:55:00+00:00 https://investor.paxmangroup.com/mfn_news/cms-foreslar-nya-ersattningsnivaer-for-mekanisk-skalpkylning-i-medicare-physician-fee-schedule-2026/ 2025-07-15T13:55:00+00:00 https://investor.paxmangroup.com/mfn_news/outpatient-prospective-payment-system-opps-proposed-rule-assigns-2026-payment-rates-for-mechanical-scalp-cooling/ 2025-07-16T10:08:00+00:00 https://investor.paxmangroup.com/mfn_news/cms-foreslar-nya-ersattningsnivaer-for-mekanisk-skalpkylning-i-outpatient-prospective-payment-system-2026/ 2025-07-16T10:08:00+00:00 https://investor.paxmangroup.com/mfn_news/invitation-to-the-presentation-of-paxmans-q2-report-on-20-august/ 2025-08-18T14:00:00+00:00 https://investor.paxmangroup.com/mfn_news/inbjudan-till-presentationen-av-paxmans-delarsrapport-for-q2-den-20-augusti/ 2025-08-18T14:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q2-2025/ 2025-08-20T05:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-kvartalsrapport-per-30-juni-2025/ 2025-08-20T05:00:00+00:00 https://investor.paxmangroup.com/mfn_news/see-richard-paxman-comment-on-the-q2-report/ 2025-08-20T08:30:00+00:00 https://investor.paxmangroup.com/mfn_news/se-vd-richard-paxman-kommentera-q2-rapporten/ 2025-08-20T08:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-founder-is-reducing-his-shareholding/ 2025-09-23T19:05:00+00:00 https://investor.paxmangroup.com/mfn_news/paxmans-grundare-minskar-sitt-aktieinnehav/ 2025-09-23T19:05:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-invitation-to-capital-market-day/ 2025-10-09T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-the-acceptance-of-the-paxman-limb-cryocompression-system-plcs-into-the-fdas-safer-technologies-program-step/ 2025-10-17T13:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-meddelar-att-paxman-limb-cryocompression-system-plcs-har-godkants-av-fdas-safer-technologies-program-step/ 2025-10-17T13:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-progress-of-its-clinical-trial-for-chemotherapy-induced-peripheral-neuropathy-with-latest-data-presented-at-eons18-conference-part-of-esmo-congress-2025/ 2025-10-20T12:01:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-tillkannager-framsteg-i-sin-kliniska-provning-av-cellgiftsinducerad-perifer-neuropati-med-de-senaste-data-presenterade-vid-eons18-konferensen-som-en-del-av-esmo-kongressen-2025/ 2025-10-20T12:01:00+00:00 https://investor.paxmangroup.com/mfn_news/reminder-paxman-invitation-to-capital-market-day/ 2025-10-24T08:00:00+00:00 https://investor.paxmangroup.com/mfn_news/invitation-live-presentation-with-ceo-richard-paxman-q3-2025/ 2025-11-07T10:15:00+00:00 https://investor.paxmangroup.com/mfn_news/inbjudan-livesand-presentation-med-richard-paxman-q3-2025/ 2025-11-07T10:15:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q3-2025/ 2025-11-14T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-the-interim-report-for-q3-2025/ 2025-11-14T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-that-cms-has-finalized-the-2026-medicare-payment-rates-for-mechanical-scalp-cooling-under-the-hospital-outpatient-and-physician-fee-schedule/ 2025-11-24T15:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-meddelar-att-cms-har-faststallt-de-slutliga-medicare-ersattningarna-for-2026-for-mekanisk-skalpkylning-inom-sjukhusens-oppenvard-och-ersattningssystemet-for-lakare/ 2025-11-24T15:45:00+00:00 https://investor.paxmangroup.com/mfn_news/correction-updated-information-on-opps-reimbursement/ 2025-11-24T17:41:00+00:00 https://investor.paxmangroup.com/mfn_news/rattelse-uppdaterade-uppgifter-om-ersattning-for-opps/ 2025-11-24T17:41:00+00:00 https://investor.paxmangroup.com/mfn_news/correction-further-updated-information-on-opps-reimbursement/ 2025-11-24T18:45:00+00:00 https://investor.paxmangroup.com/mfn_news/rattelse-ytterligare-uppdaterade-uppgifter-om-ersattning-for-opps/ 2025-11-24T18:45:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-510k-submission-to-the-u-s-food-and-drug-administration-fda-for-the-paxman-cryocompression-device-to-prevent-chemotherapy-induced-peripheral-neuropathy-cipn/ 2025-12-31T12:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-meddelar-att-bolaget-har-lamnat-in-en-510k-ansokan-till-fda-for-sin-kryokompressionsenhet-for-forebyggande-av-kemoterapiinducerad-perifer-neuropati-cipn/ 2025-12-31T12:50:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-announces-category-iii-cpt-codes-for-cryocompression-therapy-to-prevent-chemotherapy-induced-peripheral-neuropathy/ 2026-02-20T15:17:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-tillkannager-kategori-iii-cpt-koder-for-kryokompressionsterapi-for-att-forebygga-kemoterapiinducerad-perifer-neuropati/ 2026-02-20T15:17:00+00:00 https://investor.paxmangroup.com/mfn_news/inbjudan-livesand-presentation-med-richard-paxman-bokslutskommunike-2025/ 2026-02-23T10:30:00+00:00 https://investor.paxmangroup.com/mfn_news/invitation-live-presentation-with-ceo-richard-paxman-year-end-report-2025/ 2026-02-23T10:30:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-year-end-report-as-of-31-december-2025/ 2026-02-27T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-year-end-report-as-of-31-december-2025-2/ 2026-02-27T06:00:00+00:00 https://investor.paxmangroup.com/mfn_news/kommunike-fran-arsstamma-i-paxman-ab-publ/ 2026-06-12T09:39:42+00:00 https://investor.paxmangroup.com/mfn_news/press-release-from-paxman-abs-2026-annual-general-meeting/ 2026-06-12T09:39:42+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q1-2026/ 2026-06-12T09:39:42+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-its-interim-report-for-q1-2026-2/ 2026-06-12T09:39:42+00:00 https://investor.paxmangroup.com/mfn_news/invitation-live-presentation-with-richard-paxman-q1-2026/ 2026-06-12T09:39:42+00:00 https://investor.paxmangroup.com/mfn_news/inbjudan-livesand-presentation-med-richard-paxman-q1-2026/ 2026-06-12T09:39:42+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publishes-the-companys-annual-report-for-2025/ 2026-06-12T09:39:42+00:00 https://investor.paxmangroup.com/mfn_news/paxman-publicerar-bolagets-arsredovisning-for-2025/ 2026-06-12T09:39:42+00:00 https://investor.paxmangroup.com/mfn_news/notice-of-annual-general-meeting-in-paxman-ab-publ/ 2026-06-12T09:39:43+00:00 https://investor.paxmangroup.com/mfn_news/kallelse-till-arsstamma-i-paxman-ab-publ/ 2026-06-12T09:39:43+00:00